CHME Financials: China Medicine Corp AI Analysis



Financials

CHME Financial

China Medicine Corp

0%

$0

At close: May 06, 16:00:00 GMT-4

0%

$0

Pre-market: May 07, 07:05:23 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is CHME?

China Medicine Corp. engages in the development, manufacture, and sale of western pharmaceuticals, traditional Chinese medicines, and other healthcare products. The company is headquartered in Guangzhou, Guangdong and currently employs 281 full-time employees. The company went IPO on 2005-06-23. The firm is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The firm is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The firm's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The firm also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

CHME Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	09/30/2010	06/30/2010	03/31/2010	12/31/2009	09/30/2009
Revenue	65	17	17	10	20	19
Revenue Growth (YoY)	-4%	-11%	13%	0%	-17%	90%
Cost of Revenue	43	11	11	7	13	13
Gross Profit	22	5	6	3	6	5
Selling, General & Admin	7	2	1	1	1	0
Research & Development	2	1	0	0	0	0
Operating Expenses	10	3	2	2	2	1
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	9	3	5	2	0	4
Income Tax Expense	3	0	1	0	1	1
Net Income	0	2	4	-4	-2	3
Net Income Growth	-100%	-33%	--	--	-167%	200%
Shares Outstanding (Diluted)	39.59	39.59	39.99	18.89	15.34	15.41
Shares Change (YoY)	157%	157%	160%	24%	0%	-1%
EPS (Diluted)	0	0.05	0.1	-0.23	-0.13	0.2
EPS Growth	-100%	-73%	--	-675%	-159%	61%
Free Cash Flow	6	-4	-3	1	13	-1
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	33.84%	29.41%	35.29%	30%	30%	26.31%
Operating Margin	16.92%	11.76%	17.64%	10%	20%	21.05%
Profit Margin	0%	11.76%	23.52%	-40%	-10%	15.78%
Free Cash Flow Margin	9.23%	-23.52%	-17.64%	10%	65%	-5.26%
EBITDA	12	2	3	1	4	4
EBITDA Margin	18.46%	11.76%	17.64%	10%	20%	21.05%
D&A For EBITDA	1	0	0	0	0	0
EBIT	11	2	3	1	4	4
EBIT Margin	16.92%	11.76%	17.64%	10%	20%	21.05%
Effective Tax Rate	33.33%	0%	20%	0%	0%	25%

Follow-Up Questions

What are China Medicine Corp's key financial statements?



According to the latest financial statement (Form-10K), China Medicine Corp has a total asset of $0, Net loss of $0

What are the key financial ratios for CHME?



China Medicine Corp's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is China Medicine Corp's revenue broken down by segment or geography?



China Medicine Corp largest revenue segment is Bio-therapeutic, Non-surgical Solutions, at a revenue of 16,959,000 in the most earnings release.For geography, United States is the primary market for China Medicine Corp, at a revenue of 11,784,000.

Is China Medicine Corp profitable?



no, according to the latest financial statements, China Medicine Corp has a net loss of $0

Does China Medicine Corp have any liabilities?



no, China Medicine Corp has liability of 0

How many outstanding shares for China Medicine Corp?



China Medicine Corp has a total outstanding shares of 0

China Medicine Corp (CHME) Financial

CHME Stock Price Chart